EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

GLP-1 physiology and pharmacology along the gut-brain axis

Lisa R Beutler

Journal of Clinical Investigation · 16.01.2026 · 136 (2)

DOI: 10.1172/jci194744 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.01.2026. Verfasst von Lisa R Beutler. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Obesity, Glucagon-Like Peptide-1 Receptor Agonists, Brain. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, antiobesity medications have been modestly effective at best, with side-effect profiles that limit compliance and often preclude the long-term therapy required to maintain weight loss. Recently developed therapies based on analogs of the gut hormone glucagon-like peptide-1 (GLP-1) have transformed the medical management of obesity, leading both to a degree of weight loss that rivals bariatric surgery and a reduction in morbidity and mortality associated with obesity-related complications. GLP-1 receptor agonist (GLP-1RA) therapies were developed to mimic the peripheral effects of GLP-1, but it is now well established that their efficacy in the treatment of obesity depends on reducing energy intake through their action in the central nervous system (CNS). Recent data indicate that the aversive gastrointestinal side effects of GLP-1RAs are also CNS mediated. Although a complete understanding of the neural circuits underlying GLP-1RA–induced weight loss remains elusive, a great deal has been learned in recent years. This Review summarizes proposed gut-brain and central mechanisms through which GLP-1 and its synthetic analogs regulate food intake and bodyweight.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide 1ObesityGlucagon-Like Peptide-1 Receptor AgonistsBrainGastrointestinal TractHumansAnimalsGlucagon-Like Peptide-1 ReceptorWeight LossEating

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorGLP1R protein, human

Zitieren

APA

Beutler, L. R. (2026). GLP-1 physiology and pharmacology along the gut-brain axis. Journal of Clinical Investigation, 136(2). https://doi.org/10.1172/jci194744

Vancouver

Beutler LR. GLP-1 physiology and pharmacology along the gut-brain axis. Journal of Clinical Investigation. 2026;136(2). doi:10.1172/jci194744

BibTeX
@article{Beutler2026,
  author = {Beutler, Lisa R},
  title = {GLP-1 physiology and pharmacology along the gut-brain axis},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {2},
  doi = {10.1172/jci194744}
}
Kostenlos starten →